NasdaqCM - Delayed Quote • USD
Outlook Therapeutics, Inc. (OTLK)
At close: 4:00 PM EDT
After hours: 6:23 PM EDT
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Cash Flow
-47,104.32
-42,973.40
-56,674.56
-54,253.29
-31,790.09
Investing Cash Flow
-150.74
--
--
--
-900.00
Financing Cash Flow
5,120.10
48,968.57
59,594.05
56,194.63
37,210.55
End Cash Position
10,356.63
23,391.98
17,396.81
14,477.32
12,535.99
Interest Paid Supplemental Data
1.00
1,160.01
1,556.69
46.24
913.97
Issuance of Capital Stock
5,387.20
30,024.21
62,307.31
46,301.84
35,430.73
Issuance of Debt
--
30,000.00
10,000.00
10,000.00
904.20
Repayment of Debt
-12.14
-10,231.75
-12,319.11
-3,692.56
-263.28
Free Cash Flow
-47,104.32
-42,973.40
-56,674.56
-54,253.29
-31,790.09
9/30/2020 - 6/14/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ATNM Actinium Pharmaceuticals, Inc.
6.87
+4.73%
FULC Fulcrum Therapeutics, Inc.
7.14
+0.14%
MRNS Marinus Pharmaceuticals, Inc.
1.4050
-1.06%
OCUL Ocular Therapeutix, Inc.
4.7450
+12.98%
CRMD CorMedix Inc.
5.31
+2.31%
GANX Gain Therapeutics, Inc.
3.0300
-1.30%
AVTX Avalo Therapeutics, Inc.
15.94
+6.41%
STOK Stoke Therapeutics, Inc.
12.41
+6.16%
EYEN Eyenovia, Inc.
0.6282
-11.68%
CADL Candel Therapeutics, Inc.
6.39
-0.62%